Product ID: SQMIG35G2180
Report ID:
SQMIG35G2180 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
36 |
Figures:
74
Cancer Gene Therapy Market size was valued at USD 1.97 billion in 2021 and is poised to grow from USD 2.37 billion in 2022 to USD 10.48 billion by 2030, growing at a CAGR of 20.42% in the forecast period (2023-2030).
The global cancer gene therapy market is witnessing significant growth and is driven by advancements in genetic research and therapeutic approaches.
Gene therapy holds immense potential in the treatment of cancer, as it allows for targeted and precise interventions at the genetic level. The market is driven by the increasing prevalence of cancer worldwide, the demand for personalized medicine, and the growing adoption of gene therapy as a promising treatment option.
Additionally, ongoing research and development efforts, favorable regulatory policies, and collaborations between academic institutions and pharmaceutical companies contribute to the market's growth.
However, challenges such as high treatment costs, the complex nature of gene therapy, and the need for rigorous clinical trials and regulatory approvals pose restraints to the market's expansion. Nevertheless, the growing understanding of cancer genetics and the continuous innovation in gene therapy techniques are expected to fuel the market's progress in the coming years.
US Cancer Gene Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35G2180